NEW YORK (Feb. 25, 2011) — Using a sophisticated imaging test to probe for higher-level cognitive functioning in severely brain-injured patients provides a window into consciousness — but the view it presents is one that is blurred in fascinating …
NEW YORK (Feb. 10, 2011) — A new clinical trial at NewYork-Presbyterian Hospital/Weill Cornell Medical Center is among the first to test surgery specifically for Type 2 diabetes. The aim of the study is to understand whether surgery can control d…
NEW YORK (Nov. 3, 2010) — Scientists at Weill Cornell Medical College have taken an important step toward a better understanding of prostate cancer by uncovering evidence that it is not one disease, as previously believed, but rather several factors…
NEW YORK (Nov. 3, 2010) — Diffuse large B-cell lymphoma (DLBCL) is a type of aggressive non-Hodgkin’s lymphoma that accounts for approximately 40 percent of lymphomas among adults. If left untreated, it is fatal. The existing treatments have a c…
NEW YORK (November 2, 2010) — For patients with the most common form of hepatitis C being treated for the first time, the addition of an investigational hepatitis C — specific protease inhibitor called telaprevir to the current standard therapy mar…
NEW YORK (Oct. 28, 2010) — Scientists at Weill Cornell Medical College have identified a potential new treatment for the Nipah and Hendra viruses, two lethal and emerging viruses for which there is currently no treatment or vaccine available. The a…
NEW YORK (August 20, 2010) — Casual smokers may think that smoking a few cigarettes a week is “no big deal.” But according to new research from physician-scientists at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, having an infrequent…